Home Articles Page 25

Articles

Welcome to the ARCHIVE of Pharma Marketing News articles. All articles are FREE! No subscription is required to download these articles from past issues. Articles become available to non-subscribers approximately two months after publication. To obtain articles as soon as they are published, you must subscribe to the email newsletter service. Subscription is free and supported by advertising.

2014 Was a Good Year for FDA & Pharma: Banging Year for Drug Approvals,...

The FDA approved a total of 41 new molecular entities (NMEs) and biologics (BLAs) in 201 4but sent out only a meager 10 advertising enforcement letters in 2014, the fewest ever.

A KOL by Any Other Name: Too Toxic for Everyday Use, or Still the...

This article summarizes the results of the KOL Name Change Survey and discusses how to change the underlying process by which pharma companies choose KOLs.

Pharma Marketing News Vol. 14, No. 1: January 2015

Welcome to Volume 14, Issue #1 (JANUARY 2015) of Pharma Marketing News.

The Year 2014 in Images: Pharmaguy’s Favorites from Pharma Marketing Blog

In this article, Pharmaguy presents the best images from Pharma Marketing Blog, which cover topics of importance in 2014: DTC and drug promotion spending, drug risks and adverse events, drug industry reputation, FDA and social media regulatory guidelines, mobile apps, and drug development costs.

2015 New Year’s Resolutions for Pharma: Focus on Mobile, DTC, Patients, Prices, etc.

Here's John Mack's list of 2015 resolutions for pharmaceutical marketers. Hopefully, at least one of these will be kept, although no one is making any promises.

Are Drug.com Websites “Fair and Balanced?”: FDA Studies Online DTC Prescription Drug Promotion

This article reviews the study 'Examination of Online Direct-to-Consumer Prescription Drug Promotion' (FDA-2011-N-0230), which is designed to test different ways of presenting prescription drug risk and benefit information on branded drug Web sites.

FDA To Study DTC Promotion Directed at Adolescents: Focus is on Immediate Benefits vs....

This article is a review of the proposed FDA 'Experimental Study of Direct-to-Consumer Promotion Directed at Adolescents' (FR # FDA-2013-N-1151), which aims to assess how adolescents interpret drug risk in DTC advertising.

Does Your Spouse Influence Your DTC Viewing Experience?: FDA Wants to Peek Into Your...

This article is a review of FDA's proposed study titled 'Spousal Influence on Consumer Understanding of and Response to Direct-To-Consumer Prescription Drug Advertisements' (FDA-2014-N-1819)

Pharma Marketing News Vol. 13, No. 10: December 2014

Welcome to Volume 13, Issue #10 (DECEMBER 2014) of Pharma Marketing News.

Correcting Independent 3rd-Party ‘Misinformation’ About Prescription Drugs

This article summarized the industry's response to the second FDA social media guidance document regarding correcting and/or responding to misinformation related to a firm's own FDA-approved products when that information is created or disseminated by independent third parties on the Internet or through social media.

Pharma Marketing News, Blog Posts, Events, Podcasts

- Advertisement -